健脾清肠法改善化疗致结直肠癌患者肠屏障功能障碍的临床观察
DOI:
作者:
作者单位:

上海中医药大学附属曙光医院,上海 201203

作者简介:

通讯作者:

中图分类号:

R273

基金项目:

基金项目: 上海市卫生局科研项目(20139173);上海市教委科研项目(2013JW045) 收稿日期: 2014 - 03 - 21 作者简介: 付晓伶(1978-),女,黑龙江齐齐哈尔人,主治医师,研究方向:中医药防治大肠癌临床研究。 △通信作者:周荣耀,E-mail:zhoury1357@hotmail.com


Clinical Observation on Therapeutic Effects of Strengthening Spleen and Clearing Intestinal Treatment on Intestinal Barrier Dysfunction in Patients after Chemotherapy with Colorectal Cancer
Author:
Affiliation:

Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
    摘要:

    目的观察健脾清肠法改善化疗致结直肠癌患者肠黏膜屏障功能障碍的临床疗效,并探讨可能作用机制。方法采用随机同期对照原则,将82例患者分成空白对照组26例(予单纯化疗)、培菲康组26例(予培菲康联合化疗)和中药组30例(予健脾清肠方药联合化疗),经治疗2个月,分别于治疗前后对结直肠癌患者予KPS行为状态评分,中医证侯总积分和单项症状积分,并检测血浆内毒素含量和尿乳果糖/甘露醇排泄率。结果中药组治疗后患者KPS评分显著高于对照组(P<0.05),其改善脾虚湿热证有效率为83.33%,显著高于对照组(P<0.05)。健脾清肠方药对“大便溏薄”、“腹痛”、“纳呆”、“肠鸣”、“倦怠乏力”、“面色萎黄”症状改善明显(P<0.05),而空白对照组和培菲康组症状出现不同程度加重。对“大便溏薄”、症状改善与培菲康组作用相近(P>0.05),中药组治疗后血浆内毒素含量、尿乳果糖/甘露醇排泄率均显著降低(P<0.05);且与培菲康组作用相近(P>0.05)。结论具有健脾清肠功效的中药能修复结直肠癌患者肠黏膜屏障损伤和改善脾虚湿热证的临床症状,提高生活质量。其可能机制主要是通过降低血内毒素含量和尿乳果糖/甘露醇比值,从而减少肠黏膜屏障通透性改变,改善肠屏障功能障碍。

    Abstract:

    Objective To observe the clinical effects of“strengthening spleen and clearing intestinal treatment ”on intestinal barrier dysfunction in patients after chemotherapy with colorectal cancer, and its mechanism. Methods 82 cases of intestinal barrier dysfunction in patients after chemotherapy with colorectal cancer were divided into three groups, the blank control group in which 26 cases were treated by single chemotherapy, the control group of Bifico in which 26 cases were treated by Bifico, while the treatment group of traditional Chinese medicine were given strengthening spleen and clearing intestinal decoction. Before and after the treatment for two mouths, KPS score, overall accumulate points and single point of TCM symptoms were all aberserved, the blood endotoxin concentration and the ratio of urine lactulose to mannitol(L/M)were also detected. Results Treatment group can raise scores on the quality of life(P<0.05). The efficiency of treatment group which can improve significantly clinical symptoms of spleen deficiency and damp-heat accumulation in patients is 83. 33%(P<0.05), which is higher than the other groups. This decoction can significantly improve symptoms of “loose stool, abdomen pain, poor appetite, borborygmus, tiredness, yellow complexion”(P<0.05). The blank control group and the Bifico control group can make some symptoms aggravating in different degree. It can also produce the same effect with Bifico for “loose stool ”. (P>0.05)Strengthening spleen and clearing intestinal decoction and Bifico can all decrease significantly endotoxin, urine lactulose / mannitol ratio(P<0.05). Conclusion Strengthening spleen and clearing intestinal decoction can significantly ameliorate intestinal barrier dysfunction in patients with colorectal cancer, improve clinical symptoms of spleen deficiency and damp-heat accumulation

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期:
  • 出版日期:

温馨提示

关闭